Literature DB >> 22388326

National Heart, Lung, and Blood Institute Workshop: improving outcomes for pulmonary vascular disease.

Ivan M Robbins1, Timothy M Moore, Carol J Blaisdell, Steven H Abman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22388326      PMCID： PMC7398123          DOI： 10.1161/CIRCULATIONAHA.112.092924

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  11 in total

Review 1.  Pulmonary arterial hypertension associated with systemic sclerosis.

Authors:  Stephen C Mathai; Paul M Hassoun
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

2.  Pulmonary arterial hypertension in France: results from a national registry.

Authors:  Marc Humbert; Olivier Sitbon; Ari Chaouat; Michèle Bertocchi; Gilbert Habib; Virginie Gressin; Azzedine Yaici; Emmanuel Weitzenblum; Jean-François Cordier; François Chabot; Claire Dromer; Christophe Pison; Martine Reynaud-Gaubert; Alain Haloun; Marcel Laurent; Eric Hachulla; Gérald Simonneau
Journal:  Am J Respir Crit Care Med       Date:  2006-02-02       Impact factor: 21.405

Review 3.  Updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

4.  Usefulness of serial N-terminal pro-B-type natriuretic peptide measurements for determining prognosis in patients with pulmonary arterial hypertension.

Authors:  Gert-Jan Mauritz; Dimitris Rizopoulos; Herman Groepenhoff; Henning Tiede; Janine Felix; Paul Eilers; Joachim Bosboom; Pieter E Postmus; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  Am J Cardiol       Date:  2011-09-03       Impact factor: 2.778

5.  Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.

Authors:  Marc Humbert; Olivier Sitbon; Ari Chaouat; Michèle Bertocchi; Gilbert Habib; Virginie Gressin; Azzedine Yaïci; Emmanuel Weitzenblum; Jean-François Cordier; François Chabot; Claire Dromer; Christophe Pison; Martine Reynaud-Gaubert; Alain Haloun; Marcel Laurent; Eric Hachulla; Vincent Cottin; Bruno Degano; Xavier Jaïs; David Montani; Rogério Souza; Gérald Simonneau
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

6.  Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France.

Authors:  Alain Fraisse; Xavier Jais; Jean-Marc Schleich; Sylvie di Filippo; Pascale Maragnès; Maurice Beghetti; Virginie Gressin; Michel Voisin; Claire Dauphin; Pierre Clerson; François Godart; Damien Bonnet
Journal:  Arch Cardiovasc Dis       Date:  2010-02-11       Impact factor: 2.340

7.  Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001-2006.

Authors:  S G Haworth; A A Hislop
Journal:  Heart       Date:  2008-10-24       Impact factor: 5.994

8.  Primary pulmonary hypertension. A national prospective study.

Authors:  S Rich; D R Dantzker; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; S K Koerner
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

Review 9.  Genetics and genomics of pulmonary arterial hypertension.

Authors:  Rajiv D Machado; Oliver Eickelberg; C Gregory Elliott; Mark W Geraci; Masayuki Hanaoka; James E Loyd; John H Newman; John A Phillips; Florent Soubrier; Richard C Trembath; Wendy K Chung
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

10.  A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011.

Authors:  Maria Jesus Del Cerro; Steven Abman; Gabriel Diaz; Alexandra Heath Freudenthal; Franz Freudenthal; S Harikrishnan; Sheila G Haworth; Dunbar Ivy; Antonio A Lopes; J Usha Raj; Julio Sandoval; Kurt Stenmark; Ian Adatia
Journal:  Pulm Circ       Date:  2011       Impact factor: 3.017
View more
  10 in total

1.  Survival protection by bodyweight in isolated scleroderma-related pulmonary artery hypertension.

Authors:  Carlo Marini; Bruno Formichi; Carolina Bauleo; Claudio Michelassi; Edoardo Airò; Giuseppe Rossi; Carlo Giuntini
Journal:  Intern Emerg Med       Date:  2016-04-06       Impact factor: 3.397

2.  Umbilical cord blood metabolomics reveal distinct signatures of dyslipidemia prior to bronchopulmonary dysplasia and pulmonary hypertension.

Authors:  Michael R La Frano; Johannes F Fahrmann; Dmitry Grapov; Theresa L Pedersen; John W Newman; Oliver Fiehn; Mark A Underwood; Karen Mestan; Robin H Steinhorn; Stephen Wedgwood
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-08-16       Impact factor: 5.464

Review 3.  Harnessing Big Data to Advance Treatment and Understanding of Pulmonary Hypertension.

Authors:  Christopher J Rhodes; Andrew J Sweatt; Bradley A Maron
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

4.  Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.

Authors:  John H Newman; Stuart Rich; Steven H Abman; John H Alexander; John Barnard; Gerald J Beck; Raymond L Benza; Todd M Bull; Stephen Y Chan; Hyung J Chun; Declan Doogan; Jocelyn Dupuis; Serpil C Erzurum; Robert P Frantz; Mark Geraci; Hunter Gillies; Mark Gladwin; Michael P Gray; Anna R Hemnes; Roy S Herbst; Adrian F Hernandez; Nicholas S Hill; Evelyn M Horn; Kendall Hunter; Zhi-Cheng Jing; Roger Johns; Sanjay Kaul; Steven M Kawut; Tim Lahm; Jane A Leopold; Greg D Lewis; Stephen C Mathai; Vallerie V McLaughlin; Evangelos D Michelakis; Steven D Nathan; William Nichols; Grier Page; Marlene Rabinovitch; Jonathan Rich; Franz Rischard; Sharon Rounds; Sanjiv J Shah; Victor F Tapson; Naomi Lowy; Norman Stockbridge; Gail Weinmann; Lei Xiao
Journal:  Am J Respir Crit Care Med       Date:  2017-06-15       Impact factor: 21.405

Review 5.  Interdisciplinary networks for the treatment of childhood pulmonary vascular disease: what pulmonary hypertension doctors can learn from pediatric oncologists.

Authors:  Georg Hansmann
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

6.  PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics.

Authors:  Anna R Hemnes; Gerald J Beck; John H Newman; Aiden Abidov; Micheala A Aldred; John Barnard; Erika Berman Rosenzweig; Barry A Borlaug; Wendy K Chung; Suzy A A Comhair; Serpil C Erzurum; Robert P Frantz; Michael P Gray; Gabriele Grunig; Paul M Hassoun; Nicholas S Hill; Evelyn M Horn; Bo Hu; Jason K Lempel; Bradley A Maron; Stephen C Mathai; Mitchell A Olman; Franz P Rischard; David M Systrom; W H Wilson Tang; Aaron B Waxman; Lei Xiao; Jason X-J Yuan; Jane A Leopold
Journal:  Circ Res       Date:  2017-10-27       Impact factor: 17.367

7.  Discovery of Distinct Immune Phenotypes Using Machine Learning in Pulmonary Arterial Hypertension.

Authors:  Andrew J Sweatt; Haley K Hedlin; Vidhya Balasubramanian; Andrew Hsi; Lisa K Blum; William H Robinson; Francois Haddad; Peter M Hickey; Robin Condliffe; Allan Lawrie; Mark R Nicolls; Marlene Rabinovitch; Purvesh Khatri; Roham T Zamanian
Journal:  Circ Res       Date:  2019-03-15       Impact factor: 17.367

Review 8.  NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification: JACC State-of-the-Art Review.

Authors:  William M Oldham; Anna R Hemnes; Micheala A Aldred; John Barnard; Evan L Brittain; Stephen Y Chan; Feixiong Cheng; Michael H Cho; Ankit A Desai; Joe G N Garcia; Mark W Geraci; Susan D Ghiassian; Kathryn T Hall; Evelyn M Horn; Mohit Jain; Rachel S Kelly; Jane A Leopold; Sara Lindstrom; Brian D Modena; William C Nichols; Christopher J Rhodes; Wei Sun; Andrew J Sweatt; Rebecca R Vanderpool; Martin R Wilkins; Beth Wilmot; Roham T Zamanian; Joshua P Fessel; Neil R Aggarwal; Joseph Loscalzo; Lei Xiao
Journal:  J Am Coll Cardiol       Date:  2021-04-27       Impact factor: 27.203

Review 9.  Addressing the challenges of phenotyping pediatric pulmonary vascular disease.

Authors:  Kara N Goss; Allen D Everett; Peter M Mourani; Christopher D Baker; Steven H Abman
Journal:  Pulm Circ       Date:  2017-01-01       Impact factor: 3.017

10.  Factors determining change in treatment for ambulatory children with pulmonary arterial hypertension: Implications for monitoring.

Authors:  Paul J Critser; Shane L Collins; Eleni G Elia; Julia McSweeney; Brienne Leary; Lynn A Sleeper; Mary P Mullen
Journal:  Pulm Circ       Date:  2022-07-01       Impact factor: 2.886
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.